BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37099712)

  • 21. Influence of left ventricular ejection fraction on morbidity and mortality after aortic root replacement.
    Langer NB; Ando M; Simpson M; van Boxtel BS; Sorabella RA; Patel V; George I; Smith CR; Takayama H
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):984-991.e1. PubMed ID: 30578054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of off-pump coronary artery grafting for patients with impaired left ventricular ejection fraction: A retrospective cohort study from a single institutional database.
    Jiang R; Wang Y; Pang L; Sun X; Chu X; Wang F; Huang J
    J Card Surg; 2021 Jun; 36(6):1935-1942. PubMed ID: 33665893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Carreras ET; Kaneko T; Ramirez-Del Val F; Pelletier MP; Sobieszczyk PS; Bhatt DL; Shah PB
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):798-805. PubMed ID: 28988432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.
    Butler J; Zheng Y; Khan MS; Bonderman D; Lund LH; deFilippi CR; Blaustein RO; Ezekowitz JA; Freitas C; Hernandez AF; O'Connor CM; Voors AA; Westerhout CM; Lam CSP; Armstrong PW;
    JACC Heart Fail; 2023 May; 11(5):583-592. PubMed ID: 37137660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Reliability of Automated Three-Dimensional Echocardiography-HeartModel
    Naser N; Stankovic I; Neskovic A
    Med Arch; 2022 Aug; 76(4):259-266. PubMed ID: 36313951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.
    Maes F; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto W; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Salah-Annabi M; Pelletier-Beaumont E; Côté M; Puri R; Pibarot P; Rodés-Cabau J
    JAMA Cardiol; 2019 Jan; 4(1):64-70. PubMed ID: 30566185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.
    de Groote P; Fertin M; Duva Pentiah A; Goéminne C; Lamblin N; Bauters C
    Circ Heart Fail; 2014 May; 7(3):434-9. PubMed ID: 24563449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of baseline left ventricular ejection fraction on long-term outcomes in cardiac contractility modulation therapy.
    Yücel G; Fastner C; Hetjens S; Toepel M; Schmiel G; Yazdani B; Husain-Syed F; Liebe V; Rudic B; Akin I; Borggrefe M; Kuschyk J
    Pacing Clin Electrophysiol; 2022 May; 45(5):639-648. PubMed ID: 35262210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes.
    Gevaert AB; Tibebu S; Mamas MA; Ravindra NG; Lee SF; Ahmad T; Ko DT; Januzzi JL; Van Spall HGC
    ESC Heart Fail; 2021 Aug; 8(4):2741-2754. PubMed ID: 33934542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
    Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
    BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI.
    Pilgrim T; Wenaweser P; Meuli F; Huber C; Stortecky S; Seiler C; Zbinden S; Meier B; Carrel T; Windecker S
    PLoS One; 2011; 6(11):e27556. PubMed ID: 22102909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with left ventricular ejection fraction greater than 58 % have fewer incidences of future acute decompensated heart failure admission and all-cause mortality.
    Goto T; Wakami K; Fukuta H; Fujita H; Tani T; Ohte N
    Heart Vessels; 2016 May; 31(5):734-43. PubMed ID: 25771802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort.
    Yeh JK; Hsiao YC; Jian CR; Wang CH; Wen MS; Kuo CT; Tsai FC; Wu VC; Chen TH
    PLoS One; 2016; 11(1):e0145514. PubMed ID: 26752417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Long-Term Outcome of Isolated Surgical Aortic Valve Replacement in Aortic Regurgitation With Reduced Left Ventricular Ejection Fraction and Extreme Left Ventricular Dilatation.
    Dong N; Jiang W; Yin P; Hu X; Wang Y
    Am J Cardiol; 2020 May; 125(9):1385-1390. PubMed ID: 32139161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left Ventricular Size and Outcomes in Patients With Left Ventricular Ejection Fraction Less Than 20.
    Fukunaga N; Ribeiro RVP; Lafreniere-Roula M; Manlhiot C; Badiwala MV; Rao V
    Ann Thorac Surg; 2020 Sep; 110(3):863-869. PubMed ID: 32074501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Left Ventricular Ejection Fraction with Mortality and Hospitalizations.
    Angaran P; Dorian P; Ha ACT; Thavendiranathan P; Tsang W; Leong-Poi H; Woo A; Dias B; Wang X; Austin PC; Lee DS
    J Am Soc Echocardiogr; 2020 Jul; 33(7):802-811.e6. PubMed ID: 32164977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of improvement of left ventricular systolic function after catheter ablation of persistent atrial fibrillation in patients with heart failure with reduced ejection fraction.
    Ukita K; Egami Y; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Yano M; Shutta R; Sakata Y; Nishino M; Tanouchi J
    Heart Vessels; 2021 Aug; 36(8):1212-1218. PubMed ID: 33744995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.